Phosphatidylcholine induces growth inhibition of hepatic cancer by apoptosis via death ligands

Hepato-Gastroenterology

Volumn 56, Issue 90, 2009, Pages 481-484

  Sakakima, Yoshikazu ^a   Hayakawa, Akemi ^b   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Apoptosis; Death ligand; Hepatocellular carcinoma; Lecithin; Phosphatidylcholine

Indexed keywords

CASPASE 3; CASPASE 8; FAS LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LABORATORY TEST; LIVER CANCER; LIVER CARCINOGENESIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; LIVER NEOPLASMS; PHOSPHATIDYLCHOLINES; POLY(ADP-RIBOSE) POLYMERASES; STATISTICS, NONPARAMETRIC; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 67649216255     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Niederau C, Strohmeyer G, Heintges T, et al: Polyun-saturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group. Hepatogastroenterology 1998; 45:797-804.
2. Yoshida LS, Miyazawa T, Fujimoto K, et al: Liver phos-phatidylcholine hydroperoxidation provoked by ethionine-containing choline-deficient diet in mice. Lipids 1990; 25:565-569.
3. Shinozuka H, Lombardi B, Sell S, et al: Enhancement of DL-ethionine-induced liver carcinogenesis in rats fed a choline-devoid diet. J Natl Cancer Inst 1978; 61:813-817.
4. Yokoyama S, Sells MA, Reddy TV, et al: Hepatocarcino-genic and promoting action of a choline-devoid diet in the rat. Cancer Res 1985; 45:2834-2842.
5. Ghoshal AK, Farber E: Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective. Lab Invest 1993; 68:255-260.
6. Shinozuka H, Lombardi B, Sell S, et al: Early histolog-ical and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet; Cancer Res 1978; 38:1092-1098.
7. Sakakima Y, Hayakawa A, Nagasaka T, et al: Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: In vitro and in vivo experiments. J Hepatol 2007; 47:83-92.
8. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4354.
9. Tessitore L, Marengo B, Vance DE, et al: Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas. Oncology 2003; 65:152-158.
10. Tessitore L, Dianzani I, Cui Z, et al: Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis. Biochem J 1999; 337:23-27.
11. Cui Z, Houweling M, Vance DE: Suppression of rat hepatoma cell growth by expression of phosphatidylethanolamine N-methyltransferase-2. J Biol Chem 1994; 269:24531-24533.
12. Houweling M, Cui Z, Tessitore L, et al: Induction of hepatocyte proliferation after partial hepatectomy is accompanied by a markedly reduced expression of phosphatidylethanolamine N-methyltransferase-2. Biochim BiophysActa 1997; 1346:1-9.
13. Tessitore L, Sesca E, Vance DE: Inactivation of phosphatidylethanolamine N-methyltransferase-2 in aflatoxin-induced liver cancer and partial reversion of the neoplastic phenotype by PEMT transfection of hepatoma cells. Int J Cancer 2000; 86:362-367.
14. Cui Z, Houweling M, Vance DE: Expression of phos- phatidylethanolamine N-methyltransferase-2 in Mcardle RH7777 hepatoma cells inhibits the CDP-choline pathway for phosphatidylcholine biosynthesis via decreased gene expression of CTP: phosphocholine cytidylyltransferase. Biochem J 1995; 312:939-945.
15. Dong H, Wang J, Li C, et al: The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J Hepatol 2007; 46:915-920.